A population-based study of smoking, serum cotinine and exhaled nitric oxide among asthmatics and a healthy population in the USA

Inhalation Toxicology

Volumn 28, Issue 14, 2016, Pages 724-730

  Xu, Xiaohui ^a   Hu, Hui ^b   Kearney, Gregory D ^c   Kan, Haidong ^d   Carrillo, Genny ^e   Chen, Xinguang ^b  

^a TEXAS A AND M UNIVERSITY   (United States)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^c EAST CAROLINA UNIVERSITY   (United States)

^d FUDAN UNIVERSITY   (China)

^e TEXAS A AND M HEALTH SCIENCE CENTER   (United States)

Author keywords

Asthma; Exhaled nitric oxide; NHANES; Serum cotinine; Smoking

Indexed keywords

COTININE; NITRIC OXIDE;

ADOLESCENT; ADULT; AGED; ARTICLE; ASTHMA; CHILD; CLINICAL PRACTICE; CONTROLLED STUDY; DRUG BLOOD LEVEL; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PASSIVE SMOKING; PRACTICE GUIDELINE; PRIORITY JOURNAL; SELF REPORT; UNITED STATES; BLOOD; EXHALATION; METABOLISM; MIDDLE AGED; NUTRITION; SMOKING; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ASTHMA; CHILD; COTININE; EXHALATION; FEMALE; HUMANS; MALE; MIDDLE AGED; NITRIC OXIDE; NUTRITION SURVEYS; SELF REPORT; SMOKING; TOBACCO SMOKE POLLUTION; UNITED STATES; YOUNG ADULT;

EID: 85006139121     PISSN: 08958378     EISSN: 10917691     Source Type: Journal    
DOI: 10.1080/08958378.2016.1264502     Document Type: Article

References (38)

1. Ansarin K, Chatkin J, Ferreira I, et al. (2001). Exhaled nitric oxide in chronic obstructive pulmonary disease:relationship to pulmonary function. Eur Respir J 17:934–8
2. Balint B, Donnelly L, Hanazawa T, et al. (2001). Increased nitric oxide metabolites in exhaled breath condensate after exposure to tobacco smoke. Thorax 56:456–61
3. Baptist AP, Li L, Dichiaro CA., (2015). The importance of atopy on exhaled nitric oxide levels in African American children. Ann Allergy Asthma Immunol 114:399–403
4. Barnes PJ, Dweik RA, Gelb AF, et al. (2010). Exhaled nitric oxide in pulmonary diseases:a comprehensive review. CHEST J 138:682–92
5. Benowitz NL., (1996). Cotinine as a biomarker of environmental tobacco smoke exposure. Epidemiol Rev 18:188–204
6. Bodis S, Haregewoin A., (1994). Significantly reduced salivary nitric oxide levels in smokers. Ann Oncol 5:371–2
7. Brody DJ, Zhang X, Kit BK, Dillon CF., (2013). Reference values and factors associated with exhaled nitric oxide:U.S. youth and adults. Respir Med 107:1682–91
8. Caraballo RS, Giovino GA, Pechacek TF., (2004). Self-reported cigarette smoking vs. serum cotinine among US adolescents. Nicotine Tobacco Res 6:19–25
9. CDC. (2013a) Questionnaires, datasets and related documentation. National Health and Nutrition Examination Survey 2013. Available from:http://www.cdc.gov/nchs/nhanes.htm. [Last accessed 9 2012]
10. CDC. (2013b) Biomonitoring Summaries–Cotinine
11. Chen E, Strunk RC, Bacharier LB, et al. (2010). Socioeconomic status associated with exhaled nitric oxide responses to acute stress in children with asthma. Brain Behav Immun 24:444–50
12. Cibella F, Cuttitta G, La Grutta S, et al. (2011). A cross-sectional study assessing the relationship between BMI, asthma, atopy, and eNO among schoolchildren. Ann Allergy Asthma Immunol 107:330–6
13. Delen FM, Sippel JM, Osborne ML, et al. (2000). Increased exhaled nitric oxide in Chronic bronchitis:comparison with asthma and COPD. CHEST J 117:695–701
14. Dweik RA, Boggs PB, Erzurum SC, et al. (2011). An official ATS clinical practice guideline:interpretation of exhaled nitric oxide levels (FENO) for clinical applications. Am J Respir Crit Care Med 184:602–15
15. Fahy JV., (2009). Eosinophilic and neutrophilic inflammation in asthma:insights from clinical studies. Proc Am Thoracic Soc 6:256–9
16. Hill G, Ruggeroli A, Pohorecki R, et al. (1995). Cigarette smoking reduces endogenous airway nitric oxide production during cardiopulmonary bypass in humans. Anesth Analg 81:170–2
17. Jarvis MJ, Russell MA, Benowitz NL, Feyerabend C., (1988). Elimination of cotinine from body fluids:implications for noninvasive measurement of tobacco smoke exposure. Am J Public Health 78:696–8
18. Johnson CL, Paulose-Ram R, Ogden CL., (2013). National Health and Nutrition Examination Survey:analytic guidelines, 1999–2010. National Center for Health Statistics. Vital Health Stat 2:161
19. Kharitonov S, Yates D, Chung K, Barnes P., (1996). Changes in the dose of inhaled steroid affect exhaled nitric oxide levels in asthmatic patients. Eur Respir J 9:196–201
20. Kharitonov SA, Robbins RA, Yates D, et al. (1995). Acute and chronic effects of cigarette smoking on exhaled nitric oxide. Am J Respir Crit Care Med 152:609–12
21. Kovesi T, Kulka R, Dales R., (2008). Exhaled nitric oxide concentration is affected by age, height, and race in healthy 9- to 12-year-old children. CHEST J 133:169–75
22. Kyerematen GA, Morgan ML, Chattopadhyay B, et al. (1990). Disposition of nicotine and eight metabolites in smokers and nonsmokers:identification in smokers of two metabolites that are longer lived than cotinine. Clin Pharmacol Therapeut 48:641–51
23. Laoudi Y, Nikasinovic L, Sahraoui F, et al. (2010). Passive smoking is a major determinant of exhaled nitric oxide levels in allergic asthmatic children. Allergy 65:491–7
24. Lehtimäki L, Turjanmaa V, Kankaanranta H, et al. (2000). Increased bronchial nitric oxide production in patients with asthma measured with a novel method of different exhalation flow rates. Ann Med 32:417–23
25. Long JS, Ervin LH., (2000). Using heteroscedasticity consistent standard errors in the linear regression model. Am Statistic 54:217–24
26. McSharry CP, McKay IC, Chaudhuri R, et al. (2005). Short and long-term effects of cigarette smoking independently influence exhaled nitric oxide concentration in asthma. J Allergy Clin Immunol 116:88–93
27. Moncada S, Palmer R, Higgs E., (1991). Nitric oxide:physiology, pathophysiology, and pharmacology. Pharmacol Rev 43:109–42
28. Nathan CF, Hibbs JrJB., (1991). Role of nitric oxide synthesis in macrophage antimicrobial activity. Curr Opin Immunol 3:65–70
29. Node K, Kitakaze M, Yoshikawa H, et al. (1997). Reversible reduction in plasma concentration of nitric oxide induced by cigarette smoking in young adults. Am J Cardiol 79:1538–41
30. Norman V, Keith CH., (1965). Nitrogen oxides in tobacco smoke. Nature 205:915–16
31. Perkins KA, Epstein LH, Stiller RL, et al. (1990). Behavioral performance effects of nicotine in smokers and nonsmokers. Pharmacol Biochem Behav 37:11–15
32. Robbins RA, Millatmal T, Lassi K, et al. (1997). Smoking cessation is associated with an increase in exhaled nitric oxide. CHEST J 112:313–18
33. Schilling J, Holzer P, Guggenbach M, et al. (1994). Reduced endogenous nitric oxide in the exhaled air of smokers and hypertensives. Eur Respir J 7:467–71
34. See KC, Christiani DC., (2013). Normal values and thresholds for the clinical interpretation of exhaled nitric oxide levels in the US general population:results from the National Health and Nutrition Examination Survey 2007–2010. Chest 143:107–16
35. Taylor D, Pijnenburg M, Smith A, Jongste J., (2006). Exhaled nitric oxide measurements:clinical application and interpretation. Thorax 61:817–27
36. Thomas SR, Kharitonov SA, Scott SF, et al. (2000). Nasal and exhaled nitric oxide is reduced in adult patients with cystic fibrosis and does not correlate with cystic fibrosis genotype. CHEST J 117:1085–9
37. Tsang K, Ip S, Leung R, et al. (2001). Exhaled nitric oxide:the effects of age, gender and body size. Lung 179:83–91
38. Yates DH, Breen H, Thomas PS., (2001). Passive smoke inhalation decreases exhaled nitric oxide in normal subjects. Am J Respir Crit Care Med 164:1043–6